FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334335939> ?p ?o ?g. }

• W2334335939 endingPage "2948" @default.
• W2334335939 startingPage "2941" @default.
• W2334335939 abstract "Light-chain amyloidosis (AL) with cardiac involvement carries a poor prognosis; median untreated survival is <6 months. Three-drug therapy with bortezomib, dexamethasone, and an alkylating agent (BDex+AA) is associated with improved biomarker response rates in AL amyloidosis. This study sought to evaluate the effect of BDex+AA as a first-line treatment strategy on mortality in patients with symptomatic heart failure from AL cardiac amyloidosis. Patients newly diagnosed with symptomatic New York Heart Association (NYHA) functional class ≥II heart failure due to AL amyloidosis were retrospectively studied. Initial treatment strategy was adjudicated and propensity score analysis was used to adjust for the nonrandomized allocation of treatments. Survival was assessed using a Cox proportional hazards model after adjusting for the propensity score for receiving treatment, age, NYHA functional class, and ejection fraction. Among 106 treated patients (age 64.6 ± 11.3 years, 63% male, 76% lambda subtype), 40 received the 3-drug regimen and 66 received other regimens. Mortality was 65% overall, 48% in the BDex+AA cohort (median survival time 821 days), and 76% in patients who received other regimens (median survival time 223 days). Initial treatment with BDex+AA was associated with decreased mortality after multivariable adjustment (hazard ratio: 0.209; 95% confidence interval: 0.069 to 0.636; p = 0.006). This association remained after further adjustment for components of the Mayo Stage. Use of BDex+AA in the treatment of AL amyloidosis in patients presenting with symptomatic heart failure is associated with improved survival after adjusting for clinical variables." @default.
• W2334335939 created "2016-06-24" @default.
• W2334335939 creator A5007741137 @default.
• W2334335939 creator A5014881409 @default.
• W2334335939 creator A5026915222 @default.
• W2334335939 creator A5027510418 @default.
• W2334335939 creator A5028438824 @default.
• W2334335939 creator A5072484302 @default.
• W2334335939 creator A5087790502 @default.
• W2334335939 date "2016-06-01" @default.
• W2334335939 modified "2023-10-17" @default.
• W2334335939 title "Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure" @default.
• W2334335939 cites W1567835982 @default.
• W2334335939 cites W1794807787 @default.
• W2334335939 cites W2001594121 @default.
• W2334335939 cites W2003181078 @default.
• W2334335939 cites W2007335884 @default.
• W2334335939 cites W2012680794 @default.
• W2334335939 cites W2027076242 @default.
• W2334335939 cites W2058789242 @default.
• W2334335939 cites W2070335603 @default.
• W2334335939 cites W2098093182 @default.
• W2334335939 cites W2102450498 @default.
• W2334335939 cites W2107985278 @default.
• W2334335939 cites W2108158641 @default.
• W2334335939 cites W2124624517 @default.
• W2334335939 cites W2132750428 @default.
• W2334335939 cites W2144728882 @default.
• W2334335939 cites W2171033052 @default.
• W2334335939 cites W2332241363 @default.
• W2334335939 doi "https://doi.org/10.1016/j.jacc.2016.03.593" @default.
• W2334335939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27339491" @default.
• W2334335939 hasPublicationYear "2016" @default.
• W2334335939 type Work @default.
• W2334335939 sameAs 2334335939 @default.
• W2334335939 citedByCount "76" @default.
• W2334335939 countsByYear W23343359392016 @default.
• W2334335939 countsByYear W23343359392017 @default.
• W2334335939 countsByYear W23343359392018 @default.
• W2334335939 countsByYear W23343359392019 @default.
• W2334335939 countsByYear W23343359392020 @default.
• W2334335939 countsByYear W23343359392021 @default.
• W2334335939 countsByYear W23343359392022 @default.
• W2334335939 countsByYear W23343359392023 @default.
• W2334335939 crossrefType "journal-article" @default.
• W2334335939 hasAuthorship W2334335939A5007741137 @default.
• W2334335939 hasAuthorship W2334335939A5014881409 @default.
• W2334335939 hasAuthorship W2334335939A5026915222 @default.
• W2334335939 hasAuthorship W2334335939A5027510418 @default.
• W2334335939 hasAuthorship W2334335939A5028438824 @default.
• W2334335939 hasAuthorship W2334335939A5072484302 @default.
• W2334335939 hasAuthorship W2334335939A5087790502 @default.
• W2334335939 hasConcept C126322002 @default.
• W2334335939 hasConcept C141071460 @default.
• W2334335939 hasConcept C159654299 @default.
• W2334335939 hasConcept C17923572 @default.
• W2334335939 hasConcept C203014093 @default.
• W2334335939 hasConcept C207103383 @default.
• W2334335939 hasConcept C2776364478 @default.
• W2334335939 hasConcept C2777478702 @default.
• W2334335939 hasConcept C2778198053 @default.
• W2334335939 hasConcept C2779551797 @default.
• W2334335939 hasConcept C2779951007 @default.
• W2334335939 hasConcept C2781413609 @default.
• W2334335939 hasConcept C36394416 @default.
• W2334335939 hasConcept C44249647 @default.
• W2334335939 hasConcept C50382708 @default.
• W2334335939 hasConcept C71924100 @default.
• W2334335939 hasConcept C78085059 @default.
• W2334335939 hasConceptScore W2334335939C126322002 @default.
• W2334335939 hasConceptScore W2334335939C141071460 @default.
• W2334335939 hasConceptScore W2334335939C159654299 @default.
• W2334335939 hasConceptScore W2334335939C17923572 @default.
• W2334335939 hasConceptScore W2334335939C203014093 @default.
• W2334335939 hasConceptScore W2334335939C207103383 @default.
• W2334335939 hasConceptScore W2334335939C2776364478 @default.
• W2334335939 hasConceptScore W2334335939C2777478702 @default.
• W2334335939 hasConceptScore W2334335939C2778198053 @default.
• W2334335939 hasConceptScore W2334335939C2779551797 @default.
• W2334335939 hasConceptScore W2334335939C2779951007 @default.
• W2334335939 hasConceptScore W2334335939C2781413609 @default.
• W2334335939 hasConceptScore W2334335939C36394416 @default.
• W2334335939 hasConceptScore W2334335939C44249647 @default.
• W2334335939 hasConceptScore W2334335939C50382708 @default.
• W2334335939 hasConceptScore W2334335939C71924100 @default.
• W2334335939 hasConceptScore W2334335939C78085059 @default.
• W2334335939 hasIssue "25" @default.
• W2334335939 hasLocation W23343359391 @default.
• W2334335939 hasLocation W23343359392 @default.
• W2334335939 hasOpenAccess W2334335939 @default.
• W2334335939 hasPrimaryLocation W23343359391 @default.
• W2334335939 hasRelatedWork W154367669 @default.
• W2334335939 hasRelatedWork W187736076 @default.
• W2334335939 hasRelatedWork W206392377 @default.
• W2334335939 hasRelatedWork W2135322729 @default.
• W2334335939 hasRelatedWork W2521007040 @default.
• W2334335939 hasRelatedWork W2892264640 @default.
• W2334335939 hasRelatedWork W3045665089 @default.

• next